Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Don’t Get Lulled to Sleep by the Tiny EUR/USD Moves

EUR/USD keeps testing the green support zone, yet the bears can’t muster enough strength to break through. What are their chances of breaking below before Thanksgiving, or is another rebound more likely actually? Although EUR/USD moved down a bit earli...
Nadia Simmons | November 28, 2019 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...
Mario Hose | February 4, 2020 |

Stockhouse Media Alert: Podcasts from XFUTURE 2019

The Extraordinary Future Conference attracted more than 2,500 attendees to the Vancouver Convention Centre to gain insight from high-profile speakers and analysts on all things emerging from the cannabis and tech sector. And Stockhouse Media covered the event LI...
Stockhouse Media | September 23, 2019 |

Jan 23rd 2020, Crypto Chartbook – Passive income flow, the ultimate joy

Passive income flow, the ultimate joy It is clear that the holy grail of making money is passive income flow. Making money while you sleep should be the goal of any business venture. The quality of that sleep is determined by risk. If you have figured out a passive income...
Korbinian Koller | January 23, 2020 |

Buzz on the Bullboards: Has the November rally paid off?

Once the U.S. Thanksgiving passes, the mood in North American markets shifts as investors contend with holidays, gifts, and vacations on one hand, with the end of their fiscal years on the other. Companies also look to end the calendar year on a positive note, and any...
Jonathon Brown | November 30, 2023 |

Buzz on the Bullboards: Investor caution impacts market activity

The TSX began the week on a high note, buoyed by strength in the financial and industrial sectors. However, by Tuesday, the market had slipped into the red, as investor caution took hold ahead of the upcoming U.S. inflation data. Luckily for investors, things rebounded si...
Jonathon Brown | 7 days ago |

Led by Sales of HETLIOZ, Vanda Increases Quarterly Revenues by 25%

Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt. Biopharmaceutical maker Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) yesterday announced financial and ...
Streetwise Reports | August 6, 2019 |

With Its Val d'Or Assets, Exploration Company 'On Track to Get Serious Attention'

The recently released resource estimate and other reasons why this Canadian firm makes a premium takeout target are provided in an iA Securities report. In a Sept. 3 research note, iA Securities analyst George Topping reported that the size, potential and location of ...
Streetwise Reports | September 9, 2019 |

ResMed Shares Set 52-Week Intraday High Price After Posting Q1 Earnings

Shares of respiratory medical device maker and software applications company ResMed Inc. traded 15% higher at times today after the firm posted positive Q1/20 earnings results. Developer and manufacturer of medical devices and cloud-based software applications that di...
Streetwise Reports | October 26, 2019 |
1 2 3 4 5